BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 6:27:00 PM | Browse: 1484 | Download: 1453
 |
Received |
|
2013-10-30 19:15 |
 |
Peer-Review Started |
|
2013-11-01 09:04 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2013-12-04 10:17 |
 |
Revised |
|
2013-12-20 18:35 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2014-03-04 10:00 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2014-03-04 10:32 |
 |
Articles in Press |
|
|
 |
Edit the Manuscript by Language Editor |
|
2014-03-11 15:49 |
 |
Typeset the Manuscript |
|
2014-04-19 19:20 |
 |
Publish the Manuscript Online |
|
2014-04-28 14:14 |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Topic Highlights |
| Article Title |
Mesenchymal stem cells help pancreatic islet transplantation to control type 1 diabetes
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Marina Figliuzzi, Barbara Bonandrini, Sara Silvani and Andrea Remuzzi |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Dr. Marina Figliuzzi, Department of Biomedical Engineering, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Via Stezzano, 87, 24126 Bergamo, Italy. marina.figliuzzi@marionegri.it |
| Key Words |
Mesenchymal stem cell; Islet transplantation; Type 1 diabetes; Vascularization; Immune modulation |
| Core Tip |
Type 1 diabetes is caused by a cell-mediated autoimmune destruction of pancreatic ? cells. The transplantation of pancreatic islets provides a cure for this disorder. In this review, we first summarize the current knowledge on the pathogenesis of type 1 diabetes and on the therapeutic options for this disorder. Next we discuss the impact of mesenchymal stem cells on vascularization and immunomodulation of islet transplantation. |
| Publish Date |
2014-04-28 14:14 |
| Citation |
Figliuzzi M, Bonandrini B, Silvani S, Remuzzi A. Mesenchymal stem cells help pancreatic islet transplantation to control type 1 diabetes. World J Stem Cells 2014; 6(2): 163-172 |
| URL |
http://www.wjgnet.com/1948-0210/full/v6/i2/163.htm |
| DOI |
http://dx.doi.org/10.4252/wjsc.v6.i2.163 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.